自引率: 24.5%
被引量: 1947
通过率: 暂无数据
审稿周期: 4
版面费用: 暂无数据
国人发稿量: 9
投稿须知/期刊简介:
Published by Elsevier Science. ISSN: 1473-0502.<br /><br />Transfusion and Apheresis Science (previously called Transfusion Science) brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice and both therapeutic and donor apheresis. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - both therapeutic and collection - are also addressed. A major feature of the journal is the "theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion science; basic science, current research and the clinical application of modern therapies are featured. The "Apheresis Listening Post" provides a forum for the discussion of topical issues specific to apheresis and focuses on the operators' viewpoint. Another feature section is "What's Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.
期刊描述简介:
Published by Elsevier Science. ISSN: 1473-0502. Transfusion and Apheresis Science (previously called Transfusion Science) brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice and both therapeutic and donor apheresis. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - both therapeutic and collection - are also addressed. A major feature of the journal is the "theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion science; basic science, current research and the clinical application of modern therapies are featured. The "Apheresis Listening Post" provides a forum for the discussion of topical issues specific to apheresis and focuses on the operators' viewpoint. Another feature section is "What's Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.
-
Enhancing clinical insight: Implementing validated questionnaires for comprehensive assessment of clinician expertise in transfusion medicine practices.
被引量：- 发表：1970
-
Relationship between mutations in severe hemophilia A and risk of inhibitor development: A large single-center study.
被引量：- 发表：1970
-
The practical use of artificial intelligence in Transfusion Medicine and Apheresis.
Blood and plasma volume calculations are a daily part of practice for many Transfusion Medicine and Apheresis practitioners. Though many formulas exist, each facility may have their own modifications to consider. ChatGPT (Generative Pre-trained Transformer) provides a new and exciting pathway for those with no programming experience to create personalized programs to meet the demands of daily practice. Additionally, this pathway creates computer programs that provide accurate and reproducible outputs. Herein, we aimed to create a step-by-step process for clinicians to create customized computer programs for use in everyday practice. We created a process of inputs to ChatGPT-40, which generated computer programming code. This code was copied and pasted into Notepad (and saved as a Python file) and Google Colaboratory to verify functionality. We validated the durability of our process by repeating it over a 5-day timeframe and by recruiting volunteers to reproduce our outputs using the suggested process. Computer code generated by ChatGPT-40 in response to our common language inputs was accurate and durable over time. The code was fully functional in both Python and Colaboratory. Volunteers reproduced our process and outputs with minimal assistance. We analyzed the practical application of ChatGPT-40 and artificial intelligence (AI) to perform daily calculations encountered in Transfusion Medicine. Our results provide a proof of concept that people with no programming experience can create customizable solutions for their own facilities. Our future work will expand to the creation of comprehensive and customizable websites designed for each individual user.
被引量：- 发表：1970
-
Cell throughput and performance ratio as quality indicators on hematopoietic stem cell apheresis: A single-center experience.
Benchmarking in CD34+ cell apheresis is crucial for optimizing resources, ensuring consistent collection performance, and ultimately, decision-making algorithms to improve donor safety. Key performance indicators such as the "performance ratio" (PR) are applied routinely in some apheresis centers, whereas this report identifies the "cell throughput" (CT) as another quality indicator in apheresis. This single-center study includes retrospective data from 117 aphereses. CT and PR were calculated based on the mononuclear cell collection (MNC) or continuous mononuclear cell collection (cMNC) protocols of the Spectra Optia® apheresis system, types of venous access, transplant settings, and mobilization regimens. CTs (× 106 CD34+ cells/min) were found to be greater in cMNC compared to MNC protocols (1.4 vs. 1.0, p = 0.0037), in allogeneic versus autologous (1.3 vs. 1.1, p = 0.0274), and in the mobilization regimen of G-CSF alone versus the G-CSF combined (1.3 vs. 1.0, p = 0.0249). In contrast, PR (%) was only statistically significant in favor of the cMNC protocol (213.0 vs. 186.8 for MNC). CT and PR are feasible quality indicators on CD34+ cell apheresis, are easy to calculate and implement, and have clinical and administrative implications. Analyzing CT and PR may strengthen the institutional criteria for selecting cMNC or MNC protocols; they may also be used to evaluate the performance of new personnel or cell separator devices or, eventually, trigger investigations for those aphereses under-collected by specific thresholds.
被引量：- 发表：1970
-
Considerations regarding the potential resurgence of transfusion-transmitted syphilis in the United States due to increasing disease incidence and use of fresh blood products.
被引量：- 发表：1970
